Merck & Co IncMRK
Price$143.81Intrinsic value$70.1851% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $66.6B+3.7% YoYTTM through 30 Jun 2026
Net Income $3.2B-81.5% YoYTTM through 30 Jun 2026
Free Cash Flow $16.1BTTM through 30 Jun 2026

Margins

Current
EBITDA Margin14.6%
Operating Margin8.9%
Net Margin4.8%

Returns

7.6%ROE
2.4%ROA
3.6%ROIC

Balance Sheet Health

Debt / Equity1.27x
Current Ratio1.32x
Net Debt$46.5B
Cash & Equivalents$6.8B

Quality Metrics

Altman Z-Score3.97
Piotroski F-Score6 / 9
FCF Margin24.1%
Rule of 4025.0
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $65B
Diluted EPS$1.25TTM
'19'20'21'22'23'24'25
FY2025: $7.28

Dividend

$1.70Per share, FY20261.13%Yield-8.2%5-yr growth

Capital Allocation

R&D Spend$30.5B
Capex Intensity5.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.